The company is targeting the substantial $100 billion virtual care market and has already secured a client base that includes some of the largest and most well-regarded healthcare organizations nationwide.

Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.

Defence Therapeutics is a publicly-traded biotechnology company working on engineering the next generation vaccines and ADC products using its proprietary platform.

Skylight Health Group is a healthcare services and technology company, working to positively impact patient health outcomes.